+++ Einfach investieren ? mit Kapitalschutz oder Teilschutz ? raiffeisenzertifikate.at ? jetzt in Zeichnung +++ -W-
26.03.2018 14:43:26

Share buy-back week 12/2018

Announcement             
26 March 2018

Coloplast – transactions in connection with share buy-back programme

As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to take place from 26 February, 2018 to 25 August, 2018.

The buy-back programme will be structured in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Regulation 2016/1052, also referred to as the "Safe Harbour" rules, which ensure that the company is protected against violation of insider legislation in connection with the buyback programme.

The following transactions have been executed during the period 19 – 23 March 2018:

DateNumber of shares Buying price Amount DKK 
19 March 2018 14,100 506.91 7,147,462.02 
20 March 2018 16,145 506.40 8,175,886.12 
21 March 2018 16,890 507.63 8,573,816.65 
22 March 2018 25,007 503.04 12,579,521.28 
23 March 2018 11,990 499.52 5,989,251.99 
Accumulated until now under the programme  325,137 512.04 166,482,516.83 

Henceforth, Coloplast owns 3,875,865 treasury B shares of DKK 1 equal to 1.79% of the company’s total share capital.

An overview showing the transaction data for the period 19 to 23 March is enclosed.

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800


For further information, please contact

Investors and analysts                                             

Ellen Bjurgert
Director, Investor Relations
Tel. +45 4911 1800/+45 4911 3376
Email: dkebj@coloplast.com

Rasmus Sørensen
Sr. Manager, Investor Relations
Tel. +45 4911 1800/ +45 4911 1786
Email: dkraso@coloplast.com
                                                                                       
Press and the media                                                  

Lina Danstrup
Sr. Media Relations Manager
Tel. 4911 2607
Email: dklina@coloplast.com

This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ about 11,000 people.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2018-03 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.

Analysen zu Coloplast A-S (B)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Coloplast A-S (B) 118,35 1,11% Coloplast A-S (B)